Literature DB >> 30698411

Tetrahedral DNA Nanostructure-Delivered DNAzyme for Gene Silencing to Suppress Cell Growth.

Lingxian Meng1, Wenjuan Ma1, Shiyu Lin1, Sirong Shi1, Yanjing Li1, Yunfeng Lin1.   

Abstract

DNAzymes are synthetic oligonucleotides that are capable of cleavaging target mRNA to exert gene-silencing activity and are considered as promising therapeutic agents. Dz13 is a DNAzyme that cleaves the mRNA of c-Jun and suppresses the growth of squamous cell carcinomas. However, DNAzymes exhibit low cellular uptake efficacy and require a suitable drug delivery system. In this study, we directly added the Dz13 sequence to the 5'-end of single-stranded DNA to form modified tetrahedral DNA nanostructures (TDN-Dz13). The TDNs were used to deliver the single-stranded DNAzyme Dz13 into cells. Dz13 delivered by the TDNs showed high cellular uptake efficiency and still maintained intracellular gene-silencing activity to cleave the target c-Jun mRNA, which reduced cell proliferation. This study may help find a convenient approach for the delivery of DNAzymes to regulate target genes.

Entities:  

Keywords:  DNA nanomaterial; DNAzymes; c-Jun; drug delivery; gene silence; proliferation

Mesh:

Substances:

Year:  2019        PMID: 30698411     DOI: 10.1021/acsami.8b22444

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  8 in total

1.  AS1411 aptamer modified carbon dots via polyethylenimine-assisted strategy for efficient targeted cancer cell imaging.

Authors:  Tingting Kong; Ronghui Zhou; Yujun Zhang; Liying Hao; Xiaoxiao Cai; Bofeng Zhu
Journal:  Cell Prolif       Date:  2019-11-05       Impact factor: 6.831

Review 2.  Tetrahedral DNA nanostructures as drug delivery and bioimaging platforms in cancer therapy.

Authors:  Ratchanee Duangrat; Anuttara Udomprasert; Thaned Kangsamaksin
Journal:  Cancer Sci       Date:  2020-07-20       Impact factor: 6.716

3.  Erythromycin loaded by tetrahedral framework nucleic acids are more antimicrobial sensitive against Escherichia coli (E. coli).

Authors:  Yue Sun; Yuhao Liu; Bowen Zhang; Shirong Shi; Tao Zhang; Dan Zhao; Taoran Tian; Qirong Li; Yunfeng Lin
Journal:  Bioact Mater       Date:  2021-01-23

Review 4.  The biological applications of DNA nanomaterials: current challenges and future directions.

Authors:  Wenjuan Ma; Yuxi Zhan; Yuxin Zhang; Chenchen Mao; Xueping Xie; Yunfeng Lin
Journal:  Signal Transduct Target Ther       Date:  2021-10-08

Review 5.  DNA-based enzymatic systems and their applications.

Authors:  Yunfei Jiao; Yingxu Shang; Na Li; Baoquan Ding
Journal:  iScience       Date:  2022-03-05

6.  Combined Self-Assembled Hendeca-Arginine Nanocarriers for Effective Targeted Gene Delivery to Bladder Cancer.

Authors:  Pu Zhang; Haibao Zhang; Bin Zheng; Heng Wang; Xiaolong Qi; Shuai Wang; Zhenghong Liu; Li Sun; Yang Liu; Xiaowen Qin; Weijiao Fan; Minghai Ma; Wing-Fu Lai; Dahong Zhang
Journal:  Int J Nanomedicine       Date:  2022-09-22

7.  Inhibition of proliferation and migration of tumor cells through phenylboronic acid-functionalized polyamidoamine-mediated delivery of a therapeutic DNAzyme Dz13.

Authors:  Jiebing Yang; Jiayuan Zhang; Jiakai Xing; Zhiyuan Shi; Haobo Han; Quanshun Li
Journal:  Int J Nanomedicine       Date:  2019-08-09

8.  Endogenous microRNA triggered enzyme-free DNA logic self-assembly for amplified bioimaging and enhanced gene therapy via in situ generation of siRNAs.

Authors:  Qinghua Jiang; Shuzhen Yue; Kaixin Yu; Tian Tian; Jian Zhang; Huijun Chu; Zhumei Cui; Sai Bi
Journal:  J Nanobiotechnology       Date:  2021-09-26       Impact factor: 10.435

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.